Polyubiquitinated PCNA Recruits the ZRANB3 Translocase to Maintain Genomic Integrity after Replication Stress

Department of Genetics, Harvard University Medical School, Boston, MA 02115, USA.
Molecular cell (Impact Factor: 14.46). 06/2012; 47(3):396-409. DOI: 10.1016/j.molcel.2012.05.024
Source: PubMed

ABSTRACT Completion of DNA replication after replication stress depends on PCNA, which undergoes monoubiquitination to stimulate direct bypass of DNA lesions by specialized DNA polymerases or is polyubiquitinated to promote recombination-dependent DNA synthesis across DNA lesions by template switching mechanisms. Here we report that the ZRANB3 translocase, a SNF2 family member related to the SIOD disorder SMARCAL1 protein, is recruited by polyubiquitinated PCNA to promote fork restart following replication arrest. ZRANB3 depletion in mammalian cells results in an increased frequency of sister chromatid exchange and DNA damage sensitivity after treatment with agents that cause replication stress. Using in vitro biochemical assays, we show that recombinant ZRANB3 remodels DNA structures mimicking stalled replication forks and disassembles recombination intermediates. We therefore propose that ZRANB3 maintains genomic stability at stalled or collapsed replication forks by facilitating fork restart and limiting inappropriate recombination that could occur during template switching events.

Download full-text


Available from: Lior Izhar, May 04, 2015
  • Source
    • "In response to replication blocks, PCNA undergoes monoubiquitination that recruits translesion polymerases and stimulates direct replication bypass. Additionally , PCNA can become polyubiquitinated with K63-linked chains to promote recombination-dependent DNA synthesis across DNA lesions by template-switching mechanisms and recruits ZRANB3 to sites of replication stress (Ciccia et al., 2012). FANCI and FANCD2 respond to DNA interstrand crosslinks that arrest replication forks and are recruited to damaged DNA where they are ubiquitinated and promote repair. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Localization to sites of DNA damage is a hallmark of DNA damage response (DDR) proteins. To identify DDR factors, we screened epitope-tagged proteins for localization to sites of chromatin damaged by UV laser microirradiation and found >120 proteins that localize to damaged chromatin. These include the BAF tumor suppressor complex and the amyotrophic lateral sclerosis (ALS) candidate protein TAF15. TAF15 contains multiple domains that bind damaged chromatin in a poly-(ADP-ribose) polymerase (PARP)-dependent manner, suggesting a possible role as glue that tethers multiple PAR chains together. Many positives were transcription factors; > 70% of randomly tested transcription factors localized to sites of DNA damage, and of these, ∼90% were PARP dependent for localization. Mutational analyses showed that localization to damaged chromatin is DNA-binding-domain dependent. By examining Hoechst staining patterns at damage sites, we see evidence of chromatin decompaction that is PARP dependent. We propose that PARP-regulated chromatin remodeling at sites of damage allows transient accessibility of DNA-binding proteins. Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.
    Cell Reports 05/2015; 11(9). DOI:10.1016/j.celrep.2015.04.053 · 8.36 Impact Factor
  • Source
    • "More than 400 proteins may interact with PCNA using two binding motifs, PCNA-interacting peptide (PIP)‐box [9] and AlkB homologue 2 PCNA-interacting motif (APIM) [10]. We and others have demonstrated that functional interaction with PCNA is mediated through APIM in several DNA repair proteins important for repair of ICLs [10] [11] [12] [13] [14]. Hence, several lines of evidence suggest that PCNA interactions through the APIM sequence are vital during cellular stress. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Non-muscle-invasive bladder cancers (NMIBCs) are tumors confined to the mucosa or the mucosa/submucosa. An important challenge in treatment of NMIBC is both high recurrence and high progression rates. Consequently, more efficacious intravesical treatment regimes are in demand. Inhibition of the cell's DNA repair systems is a new promising strategy to improve cancer therapy, and proliferating cell nuclear antigen (PCNA) is a new promising target. PCNA is an essential scaffold protein in multiple cellular processes including DNA replication and repair. More than 200 proteins, many involved in stress responses, interact with PCNA through the AlkB homologue 2 PCNA-interacting motif (APIM), including several proteins directly or indirectly involved in repair of DNA interstrand crosslinks (ICLs). In this study, we targeted PCNA with a novel peptide drug containing the APIM sequence, ATX-101, to inhibit repair of the DNA damage introduced by the chemotherapeutics. A bladder cancer cell panel and two different orthotopic models of bladder cancer in rats, the AY-27 implantation model and the dietary BBN induction model, were applied. ATX-101 increased the anticancer efficacy of the ICL-inducing drug mitomycin C (MMC), as well as bleomycin and gemcitabine in all bladder cancer cell lines tested. Furthermore, we found that ATX-101 given intravesically in combination with MMC penetrated the bladder wall and further reduced the tumor growth in both the slow growing endogenously induced and the rapidly growing transplanted tumors. These results suggest that ATX-101 has the potential to improve the efficacy of current MMC treatment in NMIBC. Copyright © 2014 Neoplasia Press, Inc. Published by Elsevier Inc. All rights reserved.
    Translational oncology 12/2014; 7(6):812-23. DOI:10.1016/j.tranon.2014.10.005 · 3.40 Impact Factor
  • Source
    • "We also commonly observed that when the two halves of the Holliday and replication fork junctions were not pre-annealed, hsHARP and dmHARP increased the annealing rate of the two halves during the final incubation (Figure S3). To test whether dmHARP was competent to disrupt D-loops as previously shown for hsHARP [10], a 90 bp D-loop was formed on a supercoiled plasmid with RecA and RPA and subsequently purified (Figure 2B, lane 1). Both hsHARP and dmHARP catalyzed D-loop disruption (lanes 2-4), but the reactions with dmHARP were less complete within the time frame of this assay. "
    [Show abstract] [Hide abstract]
    ABSTRACT: HARP (SMARCAL1, MARCAL1) is an annealing helicase that functions in the repair and restart of damaged DNA replication forks through its DNA branch migration and replication fork regression activities. HARP is conserved among metazoans. HARP from invertebrates differs by the absence of one of the two HARP-specific domain repeats found in vertebrates. The annealing helicase and branch migration activity of invertebrate HARP has not been documented. We found that HARP from Drosophila melanogaster retains the annealing helicase activity of human HARP, the ability to disrupt D-loops and to branch migrate Holliday junctions, but fails to regress model DNA replication fork structures. A comparison of human and Drosophila HARP on additional substrates revealed that both HARPs are competent in branch migrating a bidirectional replication bubble composed of either DNA:DNA or RNA:DNA hybrid. Human, but not Drosophila, HARP is also capable of regressing a replication fork structure containing a highly stable poly rG:dC hybrid. Persistent RNA:DNA hybrids in vivo can lead to replication fork arrest and genome instability. The ability of HARP to strand transfer hybrids may signify a hybrid removal function for this enzyme, in vivo.
    PLoS ONE 05/2014; 9(5):e98173. DOI:10.1371/journal.pone.0098173 · 3.23 Impact Factor
Show more